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Abstract: Providencia rettgeri (P. rettgeri) is the key organism for gastrointestinal tract infections due to its high virulence 
properties. The current study was designed to investigate the effect of Mr. Trivedi’s biofield energy treatment on P. rettgeri in 
lyophilized as well as revived state for antimicrobial susceptibility pattern, biochemical characteristics, and biotype number. The 
lyophilized strain of P. rettgeri (ATCC 9250) was divided into two parts, Group (Gr.) I: control and Gr. II: treatment. After 
biofield treatment, Gr. II was further subdivided into two parts, Gr. IIA and Gr. IIB. Gr. IIA was analyzed on day 10, while Gr. IIB 
was stored and analyzed on day 162 after revival (Study I). The revived sample of Gr. IIB was retreated on day 162 (Study II), 
and divided into three separate tubes. Tube 1 was analyzed on day 5, likewise, tube 2 and 3 were analyzed on day 10 and 15, 
respectively after their sub-culturing. All the experimental parameters were studied using automated MicroScan Walk-Away
®
 
system. The antimicrobial susceptibility and minimum inhibitory concentration were significantly improved by 71.43%, out of 
twenty-eight and 56.25%, out of thirty-two, respectively in the treated cells of P. rettgeri as compared to the control. The 
biochemical reactions also showed the significant (60.61%) alteration in the treated sample with respect to control. The biotype 
numbers were substantially changed in all the treated groups as compared to the control. Moreover, the organism was changed as 
Proteus mirabilis in all the treated groups except in Gr. IIA, as compared to the control. These results suggested that biofield 
treatment has a significant impact on P. rettgeri in lyophilized as well as revived state. 
Keywords: Providencia rettgeri, Antimicrobial Sensitivity, Minimum Inhibitory Concentration, Biofield Treatment, 
Biochemical Reaction, Biotype 
 
1. Introduction 
Providencia rettgeri (P. rettgeri) is the key organism for 
gastrointestinal tract infections due to its high virulence 
properties. The genus Providencia is facultatively anaerobic, 
chemoorganotrophic, and urease-producing Gram-negative, 
rod-shaped bacterium that are responsible for a wide spectrum 
of human infections [1, 2]. Providencia rettgeri (P. rettgeri) is 
motile by peritrichous flagella, belonging to the family of 
Enterobacteriaceae. The most remarkable biochemical 
features to characterize its biochemical abilities are positive 
reactions of urea and catalase, negative reactions of oxidase, 
hydrogen sulfide and β-galactosidase [3]. The high abundance 
of P. rettgeri is mainly in the urinary tract of the compromised 
or catheterized patient that causes gastrointestinal tract 
infections or traveler’s diarrhea [4, 5]. The virulence factors of 
P. rettgeri are lipopolysaccharide (LPS) and production of 
sidrophores, β-lactamase, and urease [6]. Ciprofloxacin, 
levofloxacin, piperacillin-tazobactam, meropenem, and 
amikacin are the choice of drugs in P. rettgeri infection. Based 
on literature, it was reported that the β-lactamase producing P. 
rettgeri had marked resistance to multiple drugs [7]. Therefore, 
due to the clinical significance of P. rettgeri, an effective 
antimicrobial therapy is very needful for human health. An 
alternative i.e. biofield energy based healing therapy is 
recently reported to alter the antimicrobial sensitivity pattern 
in a different microorganism. Biofield (putative energy fields) 
or electromagnetic based energy therapies used to promote 
health and healing had exclusively reported by National 
Institute of Health/National Center for Complementary and 
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Alternative Medicine (NIH/NCCAM) [8]. The human body 
naturally emits the waves in the form of bio-photons, which 
surrounds the body and it is commonly known as biofield. 
Therefore, the biofield consists of an electromagnetic field, 
being generated by moving electrically charged particles such 
as ions, molecule, etc. inside the human body. In the recent 
year, 2015 Prakash et al. reported that the various scientific 
instruments such as Kirlian photography, polycontrast 
interference photography (PIP) and resonance field imaging 
(RFI) can be extensively used to measure the biofield of 
human body [9]. Although, a human has the capability to 
harness the energy from environment or universe and can 
transmit it into any object(s) around the Globe. The objects 
always receive the energy and respond it into a useful way that 
is called biofield energy and the process is known as biofield 
treatment. Mr. Trivedi’s unique biofield energy treatment (The 
Trivedi Effect
®
) has been known to alter the characteristics 
features of pathogenic microbes [10, 11], an improved growth 
and productivity of plants [12, 13] and also able to alter the 
thermophysical properties of metal and ceramic in materials 
science [14, 15]. 
Due to the clinical significance of this organism and 
literature reports on biofield treatment, the present work was 
undertaken to evaluate the impact of biofield treatment 
modality on P. rettgeri in relation to the antimicrobials 
susceptibility, biochemical reactions, and biotyping. 
2. Materials and Methods 
The strain P. rettgeri, bearing the American Type Culture 
Collection (ATCC 9250) strain was procured from 
MicroBioLogics, Inc., USA. All the antimicrobial agents and 
biochemicals used in this experiment were procured from 
Sigma-Aldrich, MA, USA. The antimicrobial susceptibility, 
biochemical reactions and biotype number were estimated 
using MicroScan Walk-Away
®
 (Dade Behring Inc., West 
Sacramento, CA, USA) with Negative Breakpoint Combo 30 
(PBPC 30) panel. 
2.1. Experimental Design 
The impact of biofield treatment on tested bacterium P. 
rettgeri was evaluated in two groups- 
Group I: ATCC strain in the lyophilized state was 
considered as control. No treatment was given and the group 
was analyzed for antimicrobial sensitivity, biochemical 
reactions and biotype number as per the standard protocol. 
Group II: The lyophilized state of ATCC strain was divided 
into two parts named as Gr. IIA and Gr. IIB. Both the groups of 
ATCC strain of P. rettgeri in the lyophilized state were 
subjected to the Mr. Trivedi’s unique biofield treatment (first 
treatment). Gr. IIA was analyzed on day 10 for antimicrobial 
sensitivity, MIC, biochemical reactions and biotyping were 
performed as per the standard protocol, while Gr. IIB sample 
was stored in the lyophilized state for 162 days at -70ºC. Gr. 
IIB was further sub-divided in two separate parts named as Gr. 
IIB - Study I and Gr. IIB - Study II. 
Group IIB - Study I 
After 162 days, antimicrobial sensitivity, MIC, biochemical 
reactions and biotyping were performed as per the standard 
protocol. 
Group IIB - Study II 
The stored strain was revived from -70ºC and the revived 
culture was again subjected to Mr. Trivedi’s biofield treatment 
(re-treatment) on day 162. After biofield retreatment, the 
sample was sub-cultured into three separate tubes on three 
different days (Day 0, Day 5 and Day 10) and were analysed 
keeping the main treated tube aside. Each sample was 
analyzed after five days of its sub-culturing. 
2.2. Biofield Treatment Strategy 
The lyophilized sample of P. rettgeri was subjected to Mr. 
Trivedi’s biofield treatment (first treatment) and then stored, 
analyzed on day 10 (Gr. IIA) followed by retreatment on 162 
days in revived state (Gr. IIB, Study II) for antimicrobial 
sensitivity along with minimum inhibitory concentration 
(MIC), biochemical reactions and biotype number as per the 
standard protocol. In details, the treatment groups were 
received to Mr. Trivedi’s biofield treatment in sealed pack 
under laboratory condition. Mr. Trivedi provided the treatment 
through his energy transmission process to the treated groups 
without touching the samples. The optimum precautions were 
taken while handing over these cultures to Mr. Trivedi for 
retreatment purposes, to avoid contamination. 
2.3. Antimicrobial Susceptibility Test 
The assessment of antimicrobial sensitivity of P. rettgeri 
was carried out using automated instrument, MicroScan 
Walk-Away
®
 with NBPC 30 panel. The panel was stored at 2 
to 25ºC for analysis. The panel was allowed to equilibrate to 
room temperature before rehydration. All opened panels were 
used on the same day. The tests carried out on MicroScan were 
miniaturized of the broth dilution susceptibility test that has 
been dehydrated. Briefly, 0.1 mL of the standardized 
suspension of P. rettgeri cultured cells were pipetted into 25 
mL of inoculum water using pluronic and inverted 8 to 10 
times and inoculated, rehydrated, and then subjected to 
incubation for 16 hours at 35°C. Rehydration and inoculation 
were performed using the RENOK
®
 system with 
inoculators-D (B1013-4). Approximately 25 mL of 
standardized inoculum suspension was poured into the 
inoculum tray. The detailed experimental procedure and 
conditions were maintained as per the manufacturer's 
instructions. The antimicrobial susceptibility pattern (S: 
Susceptible, I: Intermediate; R: Resistant; and IB: Inducible 
β-lactamase positive) and MIC were determined by observing 
the lowest antimicrobial concentration that inhibits the growth 
of microbes [16]. 
2.4. Biochemical Reaction Studies 
The biochemical reactions of P. rettgeri were determined 
using MicroScan Walk-Away
®
 system with NBPC 30 panel. 
Preparation of NBPC 30 panel, inoculum followed by 
dehydration and rehydration were performed in a similar way 
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as mentioned in antimicrobial susceptibility assay for analysis 
of biochemical reactions followed by biotype number. It 
interprets the microbe’s biochemical results with the use of a 
photometric or fluorogenic reader. On the basis of nature of 
bacilli (Gram-negative or Gram-positive), it generates 
computerized reports using conventional panels, which 
utilizes the photometric reader and provide identification 
results. Before commencing the experiment, the NBPC 30 
panel was first incubated and read on the MicroScan 
Walkaway system. Then the panel was removed from the 
system and read on the Biomic system within 1 hour. 
MicroScan Walk-Away instrument consist of a database 
associated with collective information, which is essential to 
identify the group, genera, or species of the family. The 
detailed experimental procedures and conditions were 
followed as per the manufacturer's instructions [16]. 
2.5. Identification of Organism by Biotype Number 
The biotype number of P. rettgeri was determined on 
MicroScan Walk-Away
®
 processed panel data report with the 
help of biochemical reactions data. Similar experimental 
procedure was followed for identification of biotype number 
as described in biochemical reaction study, and as per 
manufacturer-recommended instructions [16]. 
3. Results and Discussion 
3.1. Antimicrobial Susceptibility Test 
The results of P. rettgeri susceptibility pattern and MIC 
values of tested antimicrobials after biofield treatment are 
shown in Table 1 and 2, respectively. The data was assessed 
and compared with respect to the control. Antimicrobial 
sensitivity assay and MIC were performed in twenty-eight and 
thirty-two antimicrobials, respectively. Overall, the treated 
cells of P. rettgeri showed a significant (78.57%) alteration 
(twenty-two out of twenty-eight) in antimicrobial 
susceptibility pattern as compared with the control. The 
sensitivity pattern of antibiotics such as amikacin and 
cefepime were converted from resistance (R) to susceptible (S) 
in all the treated groups with respect to the untreated control 
group. Several antibiotics viz. aztreonam, cefotaxime, 
cefotetan, cefoxitin, ceftazidime, cefuroxime, and cephalothin 
were changed from R to inducible β-lactamase (IB) in 
lyophilized treated groups (Gr. IIB; on day 10 and Gr. IIB; 
Study I - on day 162), while R to S in revived treated group (Gr. 
IIB; Study II) in all three days with respect to control. 
Amoxicillin/k-clavulanate ceftriaxone and 
piperacillin/tazobactam were converted from IB to S in Gr. IIB; 
Study II in all three assessment days, while remained 
unchanged i.e. IB in lyophilized treated groups (Gr. IIA and Gr. 
IIB; Study I) as compared to the control. Tobramycin was 
reported with improved antimicrobial sensitivity pattern from 
R (control) to S in all the treated groups except intermediate 
type response in Gr. IIB; Study II on day 15. The antimicrobial 
susceptibility of ticarcillin/k-clavulanate showed an improve 
response from I (control) to IB in lyophilized treated groups 
(Gr. IIA and Gr. IIB; Study I) and completely susceptible in 
revived treated group (Gr. IIB; Study II) in all the assessment 
days. Further, the antimicrobial sensitivity of gentamicin was 
changed from R to S in Gr. IIA on day 10, while R to I in Gr. 
IIB; Study I and in revived treated Gr. IIB; Study II on day 162 
except R on day 15 as compared to the control (Gr. I). 
Chloramphenicol showed R to S in Gr. IIA on day 10 while 
became R in rest of the treated groups as compared to the 
control. Cefazolin and ampicillin/sulbactam were converted 
from I to IB in lyophilized treated groups (Gr. IIA and Gr. IIB; 
Study I) and absolutely S in revived treated Gr. IIB; Study II in 
all the assessment days with respect to the control. The 
antimicrobial sensitivity of ampicillin showed R to IB 
response in Gr. IIA on day 10 while became R in rest of the 
treated groups as compared to the control. The antimicrobial 
sensitivity pattern of piperacillin was changed from IB to S in 
Gr. IIB; Study II on day 5, while IB to R in rest of the treated 
groups as compared to the control. Besides, moxifloxacin was 
converted from S to R in Gr. IIB; Study I and II except it 
showed intermediate (I) response on day 10, while remained 
same i.e. S in Gr. IIA as compared to the control. The 
antimicrobial susceptibility pattern of 
sulphamethoxazole/trimethoprim was altered from S to R all 
the treated groups except in Gr. IIA, on day 10 with respect to 
untreated cells of P. rettgeri. Six out of twenty eight (21.43%) 
antimicrobials such as ciprofloxacin, gatifloxacin, imipenem, 
levofloxacin, meropenem, and tetracycline did not show any 
alteration of sensitivity pattern after biofield treatment in all 
the treated groups as compared to the control (Table 1). 
Besides antimicrobials susceptibility, the MIC value was 
also reduced in several antimicrobials after biofield energy 
treatment on P. rettgeri. 
Certain antimicrobials such as amikacin, 
ampicillin/sulbactam, aztreonam, cefazolin, cefepime, 
cefotetan, cefoxitin, ceftazidime, and cephalothin showed 
two-fold reduction in MIC values in all the treated groups as 
compared to the control. The control MIC values of cefoxitin 
(>16 µg/mL) and cephalothin (>16 µg/mL) were well matched 
with literature reported data [17]. In this experiment, the MIC 
values of cefoxitin and cephalothin were reduced by two-fold 
after biofield energy treatment in both lyophilized as well as 
revived treated groups as compared to the control. The MIC 
values of antibiotics such as cefotaxime (>32 to ≤8 µg/mL), 
cefuroxime (>16 to ≤4 µg/mL) and ticarcillin/k-clavulanate (64 
to ≤16 µg/mL) were reduced by four-fold in all the treated 
groups as compared to the control. Moreover, the MIC values of 
ampicillin and chloramphenicol were decreased by two-fold 
(>16 to ≤8 µg/mL) in revived treated Gr. IIA on day 10 while 
remained unaltered in rest of the treated groups as compared to 
the control. The MIC value of extended spectrum β-lactamase-a 
Scrn (ESBL-a Scrn) was slightly reduced (>4 to ≤4 µg/mL) in 
all the treated groups as compared to the control. However, the 
MIC value of ESBL-b Scrn was also slightly reduced (>1 to ≤1 
µg/mL) in all the treated groups while remained same in Gr. IIB; 
Study 1 on day 162 as compared to the control. Gentamicin 
showed reduction in MIC value by two-fold (>8 to ≤4 µg/mL) 
in Gr. IIA on day 10, while slight reduction in MIC value (>8 to 
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8 µg/mL) in Gr. IIB; Study I and II (on day 5 and 10) while gave 
similar result in Gr. IIB; Study II on day 15 as compared to the 
control. Besides, the MIC value of moxifloxacin was altered by 
two-fold in all the treated groups as compared to the control 
except in Gr. IIA. Moreover, the MIC value of piperacillin was 
also altered by four-fold in Gr. IIA, Gr. IIB (Study I) and Gr. IIB; 
Study II on all three days of analysis except on day 5 as 
compared to the control (Table 2). 
Table 1. Antibiogram of Providencia rettgeri: Effect of biofield treatment on antimicrobial susceptibility. 
S. No. Antimicrobial Gr. I (Control) Gr. IIA (Day 10) Gr. IIB (Study I; Day 162) 
Gr. IIB (Study II; Day 162) 
Day 5 Day 10 Day 15 
1. Amikacin R S S S S S 
2. Amoxicillin/k-clavulanate IB IB IB S S S 
3. Ampicillin/sulbactam I IB IB S S S 
4. Ampicillin R IB R R R R 
5. Aztreonam R IB IB S S S 
6. Cefazolin I IB IB S S S 
7. Cefepime R S S S S S 
8. Cefotaxime R IB IB S S S 
9. Cefotetan R IB IB S S S 
10. Cefoxitin R IB IB S S S 
11. Ceftazidime R IB IB S S S 
12. Ceftriaxone IB IB IB S S S 
13. Cefuroxime R IB IB S S S 
14. Cephalothin R IB IB S S S 
15. Chloramphenicol R S R R R R 
16. Ciprofloxacin S S S S S S 
17. Gatifloxacin S S S S S S 
18. Gentamicin R S I I I R 
19. Imipenem S S S S S S 
20. Levofloxacin S S S S S S 
21. Meropenem S S S S S S 
22. Moxifloxacin S S R R I R 
23. Piperacillin/tazobactam IB IB IB S S S 
24. Piperacillin IB IB R S R R 
25. Tetracycline R R R R R R 
26. Ticarcillin/k-clavulanate I IB IB S S S 
27. Tobramycin R S S S S I 
28. Sulfamethoxazole/trimethoprim S S R R R R 
R: Resistant; S: Susceptible; I: Intermediate; IB: Inducible β-lactamase positive; Gr.: Group 
Table 2. Effect of biofield treatment on Providencia rettgeri to minimum inhibitory concentration (MIC) of tested antimicrobials. 
S. No. Antimicrobial Gr. I (Control) Gr. IIA (Day 10) Gr. IIB (Study I; Day 162) 
Gr. IIB (Study II; Day 162) 
Day 5 Day 10 Day 15 
1. Amikacin >32 ≤16 ≤16 ≤16 ≤16 ≤16 
2. Amoxicillin/k-clavulanate ≤8/4 ≤8/4 ≤8/4 ≤8/4 ≤8/4 ≤8/4 
3. Ampicillin/sulbactam 16/8 ≤8/4 ≤8/4 ≤8/4 ≤8/4 ≤8/4 
4. Ampicillin >16 ≤8 >16 >16 >16 >16 
5. Aztreonam >16 ≤8 ≤8 ≤8 ≤8 ≤8 
6. Cefazolin 16 ≤8 ≤8 ≤8 ≤8 ≤8 
7. Cefepime >16 ≤8 ≤8 ≤8 ≤8 ≤8 
8. Cefotaxime >32 ≤8 ≤8 ≤8 ≤8 ≤8 
9. Cefotetan >32 ≤16 ≤16 ≤16 ≤16 ≤16 
10. Cefoxitin >16 ≤8 ≤8 ≤8 ≤8 ≤8 
11. Ceftazidime >16 ≤8 ≤8 ≤8 ≤8 ≤8 
12. Ceftriaxone ≤8 ≤8 ≤8 ≤8 ≤8 ≤8 
13. Cefuroxime >16 ≤4 ≤4 ≤4 ≤4 ≤4 
14. Cephalothin >16 ≤8 ≤8 ≤8 ≤8 ≤8 
15. Chloramphenicol >16 ≤8 >16 >16 >16 >16 
16. Ciprofloxacin ≤1 ≤1 ≤1 ≤1 ≤1 ≤1 
17. ESBL-a Scrn >4 ≤4 ≤4 ≤4 ≤4 ≤4 
18. ESBL-b Scrn >1 ≤1 >1 ≤1 ≤1 ≤1 
19. Gatifloxacin ≤2 ≤2 ≤2 ≤2 ≤2 ≤2 
20. Gentamicin >8 ≤4 8 8 8 >8 
21. Imipenem ≤4 ≤4 ≤4 ≤4 ≤4 ≤4 
22. Levofloxacin ≤2 ≤2 ≤2 ≤2 ≤2 ≤2 
23. Meropenem ≤4 ≤4 ≤4 ≤4 ≤4 ≤4 
24. Moxifloxacin ≤2 ≤2 >4 >4 4 >4 
25. Nitrofurantoin >64 >64 >64 >64 >64 >64 
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S. No. Antimicrobial Gr. I (Control) Gr. IIA (Day 10) Gr. IIB (Study I; Day 162) 
Gr. IIB (Study II; Day 162) 
Day 5 Day 10 Day 15 
26. Norfloxacin ≤4 ≤4 ≤4 ≤4 ≤4 ≤4 
27. Piperacillin/tazobactam ≤16 ≤16 ≤16 ≤16 ≤16 ≤16 
28. Piperacillin ≤16 ≤16 >64 ≤16 >64 >64 
29. Tetracycline >8 >8 >8 >8 >8 >8 
30. Ticarcillin/k-clavulanate 64 ≤16 ≤16 ≤16 ≤16 ≤16 
31. Tobramycin >8 ≤4 ≤4 ≤4 ≤4 8 
32. Trimethoprim/sulfamethoxazole ≤2/38 ≤2/38 >2/38 >2/38 >2/38 >2/38 
MIC data are presented in µg/mL; Gr.: Group 
Tobramycin showed two-fold reduction in MIC value (>8 to 
≤4 µg/mL) in all the treated groups except slight reduction in 
MIC value (>8 to 8 µg/mL) in Gr. IIB; Study II on day 15 as 
compared with the control. The MIC value of 
trimethoprim/sulfamethoxazole was slightly altered in all the 
treated groups as compared to the control except in Gr. IIA, 
where it was remained unchanged. Overall, the treated cells of P. 
rettgeri showed a significant (65.63%) alteration (twenty-one 
out of thirty-two) of MIC values of tested antimicrobials as 
compared with the control. Eleven out of thirty-two (34.38%) 
antimicrobials such as amoxicillin/k-clavulanate, ceftriaxone, 
ciprofloxacin, gatifloxacin, imipenem, levofloxacin, 
meropenem, nitrofurantoin, norfloxacin, 
piperacillin/tazobactam, and tetracycline did not show any 
alteration in MIC in all the treated groups as compared to the 
control (Table 2). The organism P. rettgeri has been identified as 
virulent human uropathogens causes bacteremia during 
prolonged urinary catheterization. Based on literature, the 
organism has resistance to many common antibiotics such as 
penicillins, tetracyclines, older cephalosporins, and 
sulfamethoxazole [18]. In this experiment, the resistant pattern 
of all the tested penicillins and cephalosporins were improved 
to some extent and simultaneously reduced the MIC by upto 
four-fold after treatment with bio-energy on P. rettgeri. In recent 
years P. rettgeri has considered as a nosocomial pathogen in 
immunocompromised patients [19]. 
3.2. Biochemical Reactions Studies 
Table 3. Effect of biofield treatment on Providencia rettgeri to the biochemical reaction pattern. 
S. No. Code Biochemical Gr. I (Control) 
Gr. IIA (Day 
10) 
Gr. IIB (Study 
I; Day 162) 
Gr. IIB (Study II; Day 162) 
Day 5 Day 10 Day 15 
1. ACE Acetamide - - - - - - 
2. ADO Adonitol + + - - - - 
3. ARA Arabinose + - - - - - 
4. ARG Arginine - - - - - - 
5. CET Cetrimide - - - + - + 
6. CF8 Cephalothin + - - - - - 
7. CIT Citrate + + + + + + 
8. CL4 Colistin + + + + + + 
9. ESC Esculin hydrolysis + + - - - - 
10. FD64 Nitrofurantoin + + + + + + 
11. GLU Glucose + + + + + + 
12. H2S Hydrogen sulfide + - - - + - 
13. IND Indole - - - - - - 
14. INO Inositol + + - - - - 
15. K4 Kanamycin + - + + + + 
16. LYS Lysine + - - - - - 
17. MAL Malonate + - - - - - 
18. MEL Melibiose + - - - - - 
19. NIT Nitrate + + + + + + 
20. OF/G Oxidation-fermentation/glucose + + + + + + 
21. ONPG Galactosidase + - - - - - 
22. ORN Ornithine + - + + + + 
23. OXI Oxidase - - - - - - 
24. P4 Penicillin + + + + + + 
25. RAF Raffinose + - - - - - 
26. RHA Rhamnose + - - - - - 
27. SOR Sorbitol + - - - - - 
28. SUC Sucrose + - - - - - 
29. TAR Tartrate - - - - - - 
30. TDA Tryptophan deaminase - + + + + + 
31. TO4 Tobramycin + - - - - + 
32. URE Urea + + + + + + 
33. VP Voges-Proskauer + - + + + + 
-, (negative); +, (positive); Gr.: Group 
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The data obtained from biochemical reactions studies for 
the distinction of P. rettgeri are illustrated in Table 3. The 
study of biochemical reactions can be utilized to identify the 
enzymatic and metabolic characteristic feature of microbes. 
The microorganism can be categorically differentiated based 
on their utilization of specific biochemicals as nutrients during 
the process of enzymatic reactions or metabolism. Based on 
results from biochemical reaction tryptophan deaminase 
(TDA) was changed from negative (-) to positive (+) reaction 
in all the treated groups with respect to the control. 
Biochemicals such as arabinose (ARA), cephalothin (CF8), 
lysine (LYS), malonate (MAL), melibiose (MEL), 
galactosidase (ONPG), raffinose (RAF), rhamnose (RHA), 
sorbitol (SOR), and sucrose (SUC) were changed from 
positive (+) to negative (-) reactions in all the treated groups 
with respect to the control. Moreover, biochemical reactions 
of adonitol (ADO), esculin hydrolysis (ESC), and inositol 
(INO) were changed from positive (+) to negative (-) reactions 
in all the treated groups while remained unchanged i.e. 
positive (+) in Gr. IIA as compared to the control. 
Biochemicals such as kanamycin (K4), ornithine (ORN), and 
Voges-Proskauer (VP) were converted from positive (+) to 
negative (-) reactions in Gr. IIA on day 10 while remained 
positive (+) reaction in rest of the treated groups as compared 
to the control. Hydrogen sulfide (H2S) and tobramycin (TO4) 
showed negative (-) reactions in all the treated groups, while 
H2S and TO4 gave positive (+) reactions in Gr. IIB; Study II 
on day 10 and 15, respectively as compared with the control. 
The positive (+) reaction of H2S in control sample is the key 
characteristic feature of P. rettgeri which was altered after 
biofield treatment. Moreover, cetrimide (CET) showed the 
positive (+) reaction in Gr. IIB; Study II on day 5 and 15, while 
remained same as a negative (-) reaction in rest of the treated 
groups as compared to the control. Based on this data, it is 
assumed that Mr. Trivedi’s biofield treatment has an impact on 
P. rettgeri in terms of metabolic reaction. Overall, 60.61% 
(twenty out of thirty-three) biochemical reactions were altered 
with respect to control after biofield energy treatment. About 
39.39% out of thirty-three biochemicals, such as acetamide, 
arginine, citrate, colistin, nitrofurantoin, glucose, indole, 
nitrate, oxidation-fermentation/glucose, oxidase, penicillin, 
tartrate, and urea did not show any change in all the groups 
after biofield treatment as compared to the control (Table 3). 
Previously, many organisms under the genus of Providencia 
have been called as P. rettgeri based on urea hydrolysis 
biochemical reaction pattern while based on additional 
fermentation process the organism was reclassified as P. 
stuartii [20]. 
3.3. Identification of Organism by Biotype Number 
The species (P. rettgeri) was identified and distinguished 
based on morphological characters and biotyping. Biotype is 
defined as a group of individuals with same genotype. Biotype 
number of specific strain was evaluated after interpreting the 
results of the biochemical reactions and led to the particular 
strain identification. In the present study, biotyping was 
performed using an automated system, and results showed a 
significant change in biotype number in all the treated groups 
as compared to the control. After biofield energy treatment, an 
alteration of biotype numbers were observed in Gr. IIA on day 
10 (40640644; Providencia rettgeri), in Gr. IIB; Study I on 
day 162 (40041544; Proteus mirabilis), in Gr. IIB; Study II on 
day 5 (40041544; Proteus mirabilis), on day 10 (40061544; 
Proteus mirabilis) and on day 15 (40041544; Proteus 
mirabilis) as compared to the control (77765376; Providencia 
rettgeri) (Table 4). Brenner et al. had proposed the transfer of 
genus from Providencia to Proteus [21]. In this experiment, 
the biochemicals adonitol and inositol showed positive (+) 
reactions in control as well as in Gr. IIA that supports the 
identifiable genus Providencia, while negative (-) reactions in 
rest of the treated groups indicated the genus Proteus (Table 4). 
The results were well supported by literature data [22]. 
Although both genus i.e. Providencia and Proteus possess 
same tribe Proteeae but they have diverse characteristics [23]. 
Biofield energy treatment may be responsible for alteration in 
microorganism at enzymatic and/or genetic level, which may 
act on receptor protein and that could lead to show different 
phenotypic characteristics [24]. 
Table 4. Effect of biofield treatment on biotype number of Providencia rettgeri. 
Feature Gr. I (Control) Gr. IIA (Day 10) Gr. IIB (Study I; Day 162) 
Gr. IIB (Study II; Day 162) 
Day 5 Day 10 Day 15 
Biotype 77765376 40640644 40041544 40041544 40061544 40041544 
Organism Identification P. rettgeri P. rettgeri Proteus mirabilis Proteus mirabilis Proteus mirabilis Proteus mirabilis 
Gr.: Group 
Biofield treatment might induce significant changes in 
lyophilized as well as revived strain of P. rettgeri and 
significantly improved the antimicrobials susceptibility 
pattern, MIC. It also altered the biochemical reactions which 
ultimately change the biotype number with new 
microorganism. As a result, the microbe that was 
resistance/intermediate/inducible β-lactamase to a particular 
antimicrobial in control sample now converted into 
susceptible in the treated cells of P. rettgeri predominately 
after biofield energy treatment. Due to microbial resistance to 
a single and/or multiple drugs, the invention of an effective 
antimicrobial therapy for the human-wellness is urgently 
required. So far our group had reported many scientific 
evidence regarding the effects on Mr. Trivedi’s biofield energy 
treatment on ATCC and multidrug resistant strains [10, 11]. 
Based on these results, it is envisaged that biofield energy 
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treatment has the ability to alter the sensitivity pattern of 
antimicrobials and a positive scope to be an alternative 
integrative medicine approach than the existing antimicrobial 
therapy in near future. 
4. Conclusions 
In conclusion, the antimicrobial susceptibility pattern and 
the MIC values showed the significant 78.57% (out of 
twenty-eight) and 65.63% (out of thirty-three) alteration, 
respectively of tested antimicrobials as compared to the 
control strain of P. rettgeri. Moreover, about 71.43% 
antimicrobials sensitivity and 56.25% MIC values of tested 
antimicrobials were improved after biofield energy treatment 
to the strain of P. rettgeri. Besides, the biochemical reactions 
pattern showed the significant 60.61% alteration as compared 
to the control. Moreover, the biotype numbers of biofield 
treated strain of P. rettgeri were also changed in all the treated 
groups as compared to the control. Based on the changed 
biotype numbers after biofield treatment, new species was 
identified as Proteus mirabilis in all the treated groups except 
P. rettgeri in Gr. IIA on day 10 as compared to the control. 
Thus, Mr. Trivedi’s unique biofield energy treatment could be 
applied as an alternative therapeutic approach against 
antimicrobials to improve the antibiogram profile against 
microbes. Based on these results, it seems that biofield 
treatment could be used as an alternate of existing drug 
therapy in near future. 
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